1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

“This is part of our commitment to delivering Smarter AI for All—developing and deploying technology that can empower ...

Feeling lonely increased risk for all-cause dementia by 31 percent and cognitive impairment by 15 percent. Loneliness is a ...

ADRD represents a significant and growing global health challenge, impacting 47 million people worldwide today, with cases ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Tengrinews.kz - Kazakhstan’s President Kassym-Jomart Tokayev delivered a speech at the Climate Action Summit, part of the ...

Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022, ...

On the other hand, the Clinical Dementia Rating Scale (CDR) provides a global measure of cognitive decline across multiple domains. Research has shown that the ADAS-Cog is more sensitive to changes in ...

A recent study has discovered a food linked to increased dementia risk. Presented at the 2024 Alzheimer's Association International Conference in July, the research pointed to processed red meat.

Most cases of dementia are caused by a mixture of risk factors. A risk factor is something that affects our chances of developing a condition like dementia. For most of us our risk of dementia is made ...

In the UK, people living with certain types of dementia, can be prescribed treatments to help manage their symptoms. These are known as symptomatic treatments. They include donepezil (part of a family ...

In people with mild cognitive impairment, galantamine, compared to placebo, may make little to no difference in improving memory or the ability to do self-care activities. However, participants who ...